Wortmannin

Wortmannin

SCHEMBL18022829

COCC1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)C2CCC(=O)[C@@]2(C)CC1OC(C)=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3C3 Q8NEB9 10/20 1.00
PIK3CA P42336 8/20 1.00
PIK3R1 P27986 5/20 1.00
ALDH1A1 P00352 3/20 1.00
MAPT P10636 3/20 1.00
RECQL P46063 3/20 1.00
MTOR P42345 3/20 1.00
THRB P10828 2/20 1.00
MEN1 O00255 2/20 1.00
HPGD P15428 2/20 1.00
KMT2A Q03164 2/20 1.00
HSD17B10 Q99714 2/20 1.00
PRKDC P78527 2/20 1.00
PIK3CD O00329 2/20 1.00
PIK3CG P48736 2/20 1.00
ABCC4 O15439 1/20 1.00
ABCB11 O95342 1/20 1.00
HSP90AA1 P07900 1/20 1.00
PIK3CB P42338 1/20 1.00
PI4KA P42356 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Wortmannin SCHEMBL1147299 1.00 PIK3C3 (1.00) PIK3C3PIK3CAPIK3R1ALDH1A1MAPT
Wortmannin SCHEMBL19737003 1.00 PIK3C3 (1.00) PIK3C3PIK3CAPIK3R1ALDH1A1MAPT
Wortmannin SCHEMBL12650003 1.00 PIK3C3 (1.00) PIK3C3PIK3CAPIK3R1ALDH1A1MAPT
Wortmannin SCHEMBL4896797 1.00 PIK3C3 (1.00) PIK3C3PIK3CAPIK3R1ALDH1A1MAPT
Wortmannin SCHEMBL12162186 1.00 PIK3C3 (1.00) PIK3C3PIK3CAPIK3R1ALDH1A1MAPT
Wortmannin SCHEMBL4531 1.00 PIK3C3 (1.00) PIK3C3PIK3CAPIK3R1ALDH1A1MAPT
Wortmannin SCHEMBL14174545 1.00 PIK3C3 (1.00) PIK3C3PIK3CAPIK3R1ALDH1A1MAPT
Wortmannin SCHEMBL14233191 1.00 PIK3C3 (1.00) PIK3C3PIK3CAPIK3R1ALDH1A1MAPT
Wortmannin SCHEMBL13166020 1.00 PIK3C3 (1.00) PIK3C3PIK3CAPIK3R1ALDH1A1MAPT
Wortmannin SCHEMBL4530 1.00 PIK3C3 (1.00) PIK3C3PIK3CAPIK3R1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180104270-A1 COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES ASSOCIATED WITH ACTIVATED T CELLS AND/OR B CELLS CHILDREN'S HOSPITAL MEDICAL CENTER 2018-04-19 US disclosed
US-20160237073-A1 Novel Polymorphs and Salts GLAXO GROUP LTD (GB) 2016-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180104270-A1 COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES ASSOCIATED WITH ACTIVATED T CELLS AND/OR B CELLS TP53, NFATC1, ACIN1 PIK3C3 1249/4885PIK3CA 635/4885PIK3R1 1403/4885
US-20160237073-A1 Novel Polymorphs and Salts PRKDC, PRKACA, MAP3K20 PIK3C3 109/4885PIK3CA 133/4885PIK3R1 404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.